NatureWise Biotech & Medicals Corporation
4732
Rank in Stocks
#26122
NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily... NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.
Share Price
$0.45421844
Last synced: 2026-11-10
Market Cap
$22.01M
Change (1 day)
0.00%
Change (1 year)
-28.72%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NatureWise Biotech & Medicals Corporation (4732)
Category
Healthcare
Operating Margin for NatureWise Biotech & Medicals Corporation (4732)
Operating Margin as of November 2026 TTM: -97.46%
According to NatureWise Biotech & Medicals Corporation's latest financial reports, its current operating margin (TTM) is -97.46%. At the end of 2025 the company had an operating margin of -60.46%.
Operating Margin history for NatureWise Biotech & Medicals Corporation from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -97.46% | 61.20% |
| 2025 | -60.46% | 1,025.88% |
| 2024 | -5.37% | -350.93% |
| 2023 | 2.14% | -81.44% |
| 2022 | 11.53% | 6.76% |
| 2021 | 10.80% | -42.77% |
| 2020 | 18.87% | 76.52% |
| 2019 | 10.69% | -153.24% |
| 2018 | -20.08% | -76.86% |
| 2017 | -86.76% | -24.69% |
| 2016 | -115.21% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.40% |
US
|
|
| -149.01% | -98.47% |
US
|
|
| 25.57% | -100.26% |
AU
|
|
| 31.23% | -100.32% |
BE
|
|
| 29.35% | -100.30% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about NatureWise Biotech & Medicals Corporation's operating margin
What is NatureWise Biotech & Medicals Corporation's operating margin?
NatureWise Biotech & Medicals Corporation's operating margin is -97.46%, as of Nov 2026.
What was NatureWise Biotech & Medicals Corporation's operating margin in 2025?
In 2025, NatureWise Biotech & Medicals Corporation's operating margin was -60.46%, compared with -5.37% in 2024.
How has NatureWise Biotech & Medicals Corporation's operating margin changed since 2020?
From 2020 to 2025, NatureWise Biotech & Medicals Corporation's operating margin was highest in 2020 (18.87%) and lowest in 2025 (-60.46%).
How does NatureWise Biotech & Medicals Corporation's operating margin compare with similar companies?
NatureWise Biotech & Medicals Corporation's operating margin (-97.46%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.